Evidence map›Paper›PMID 36006071›Full record

ArticleTomography (Ann Arbor, Mich.)2022

Performance of Machine Learning and Texture Analysis for Predicting Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer with 3T MRI.

Davide Bellini, Iacopo Carbone, Marco Rengo, Simone Vicini, Nicola Panvini, Damiano Caruso, Elsa Iannicelli, Vincenzo Tombolini, Andrea Laghi

Open access · goldAbstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Davide BelliniDepartment of Radiological Sciences, Oncology and Pathology, "Sapienza" University of Rome-I.C.O.T. Hospital, Via Franco Faggiana, 1668, 04100 Latina, Italy.ORCID 0000-0002-2731-6959
Iacopo CarboneDepartment of Radiological Sciences, Oncology and Pathology, "Sapienza" University of Rome-I.C.O.T. Hospital, Via Franco Faggiana, 1668, 04100 Latina, Italy.ORCID 0000-0003-3108-7527
Marco RengoDepartment of Radiological Sciences, Oncology and Pathology, "Sapienza" University of Rome-I.C.O.T. Hospital, Via Franco Faggiana, 1668, 04100 Latina, Italy.ORCID 0000-0001-9087-5692
Simone ViciniDepartment of Radiological Sciences, Oncology and Pathology, "Sapienza" University of Rome-I.C.O.T. Hospital, Via Franco Faggiana, 1668, 04100 Latina, Italy.ORCID 0000-0002-5193-7464
Nicola PanviniDepartment of Radiological Sciences, Oncology and Pathology, "Sapienza" University of Rome-I.C.O.T. Hospital, Via Franco Faggiana, 1668, 04100 Latina, Italy.ORCID 0000-0002-0967-7101
Damiano CarusoDepartment of Surgical and Medical Sciences and Translational Medicine, "Sapienza" University of Rome-Diagnostic Imaging Unit, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.ORCID 0000-0001-9285-4764
Elsa IannicelliDepartment of Surgical and Medical Sciences and Translational Medicine, "Sapienza" University of Rome-Diagnostic Imaging Unit, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.ORCID 0000-0002-2959-4493
Vincenzo TomboliniDepartment of Radiotherapy, Policlinico Umberto I, "Sapienza" University of Rome, 00161 Rome, Italy.ORCID 0000-0001-5359-9991
Andrea LaghiDepartment of Surgical and Medical Sciences and Translational Medicine, "Sapienza" University of Rome-Diagnostic Imaging Unit, Sant'Andrea University Hospital, Via di Grottarossa 1035, 00189 Rome, Italy.ORCID 0000-0002-3091-7819
Sapienza University of Rome · ITPoliclinico Umberto I · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To evaluate the diagnostic performance of a Machine Learning (ML) algorithm based on Texture Analysis (TA) parameters in the prediction of Pathological Complete Response (pCR) to Neoadjuvant Chemoradiotherapy (nChRT) in Locally Advanced Rectal Cancer (LARC) patients. Methods: LARC patients were prospectively enrolled to undergo pre- and post-nChRT 3T MRI for initial loco-regional staging. TA was performed on axial T2-Weighted Images (T2-WI) to extract specific parameters, including skewness, kurtosis, entropy, and mean of positive pixels. For the assessment of TA parameter diagnostic performance, all patients underwent complete surgical resection, which served as a reference standard. ROC curve analysis was carried out to determine the discriminatory accuracy of each quantitative TA parameter to predict pCR. A ML-based decisional tree was implemented combining all TA parameters in order to improve diagnostic accuracy. Results: Forty patients were considered for final study population. Entropy, kurtosis and MPP showed statistically significant differences before and after nChRT in patients with pCR; in particular, when patients with Pathological Partial Response (pPR) and/or Pathological Non-Response (pNR) were considered, entropy and skewness showed significant differences before and after nChRT (all p < 0.05). In terms of absolute value changes, pre- and post-nChRT entropy, and kurtosis showed significant differences (0.31 ± 0.35, in pCR, −0.02 ± 1.28 in pPR/pNR, (p = 0.04); 1.87 ± 2.19, in pCR, −0.06 ± 3.78 in pPR/pNR (p = 0.0005); 107.91 ± 274.40, in pCR, −28.33 ± 202.91 in pPR/pNR, (p = 0.004), respectively). According to ROC curve analysis, pre-treatment kurtosis with an optimal cut-off value of ≤3.29 was defined as the best discriminative parameter, resulting in a sensitivity and specificity in predicting pCR of 81.5% and 61.5%, respectively. Conclusions: TA parameters extracted from T2-WI MRI images could play a key role as imaging biomarkers in the prediction of response to nChRT in LARC patients. ML algorithms can be used to efficiently combine all TA parameters in order to improve diagnostic accuracy.

Indexed as

Neoplasms, Second PrimaryRectal NeoplasmsChemoradiotherapyHumansMachine LearningMagnetic Resonance ImagingNeoadjuvant TherapyTreatment Outcomeartificial intelligencemachine learningmagnetic resonance imagingneoadjuvant chemoradiotherapyrectal neoplasmstexture analysis

Identifiers

PMID36006071
PMCPMC9416446
OpenAlexW4292574088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.